- No benefit, higher death rate for malaria drug in coronavirus study Yahoo Singapore News
- Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19 TODAYonline
- Drug championed by Trump for coronavirus shows no benefit, possible harm in study awaiting validation Reuters
- Study Of Hydroxychloroquine As Coronavirus Treatment Finds More Deaths, No Benefit HuffPost
- More evidence hints that hydroxychloroquine doesn’t help treat COVID-19 Science News
- View Full coverage on Google News
No benefit, higher death rate for malaria drug in coronavirus study - Yahoo Singapore News
Read More
No comments:
Post a Comment